These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 2783247

  • 1. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.
    Bhalla K, Birkhofer M, Grant S, Graham G.
    Exp Hematol; 1989 Jan; 17(1):17-20. PubMed ID: 2783247
    [Abstract] [Full Text] [Related]

  • 2. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
    Grant S, Pettit GR, McCrady C.
    Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
    [Abstract] [Full Text] [Related]

  • 3. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 4. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 5. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
    Falk LA, Wahl LM, Vogel SN.
    J Immunol; 1988 Apr 15; 140(8):2652-60. PubMed ID: 3128601
    [Abstract] [Full Text] [Related]

  • 6. Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells.
    Bhalla K, Birkhofer M, Arlin Z, Grant S, Lutzky J, Graham G.
    Leukemia; 1988 Dec 15; 2(12):810-3. PubMed ID: 3264363
    [Abstract] [Full Text] [Related]

  • 7. Modest stimulatory effect of recombinant human GM-CSF on colony growth from peripheral blood human megakaryocyte progenitor cells.
    Mazur EM, Cohen JL, Wong GG, Clark SC.
    Exp Hematol; 1987 Dec 15; 15(11):1128-33. PubMed ID: 3315723
    [Abstract] [Full Text] [Related]

  • 8. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D, Strife A, Atzpodien J, Clarkson BD.
    Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231
    [Abstract] [Full Text] [Related]

  • 9. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep 15; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 10. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells.
    Grant S, Traylor R, Bhalla K, McCrady C, Pettit GR.
    Leukemia; 1992 May 15; 6(5):432-9. PubMed ID: 1593908
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of the growth of IL-3-dependent mast cells from murine bone marrow by recombinant granulocyte macrophage-colony-stimulating factor.
    Bressler RB, Thompson HL, Keffer JM, Metcalfe DD.
    J Immunol; 1989 Jul 01; 143(1):135-9. PubMed ID: 2471732
    [Abstract] [Full Text] [Related]

  • 12. Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia.
    Motoji T, Takanashi M, Fuchinoue M, Masuda M, Oshimi K, Mizoguchi H.
    Exp Hematol; 1989 Jan 01; 17(1):56-60. PubMed ID: 2783249
    [Abstract] [Full Text] [Related]

  • 13. Interactions between purified murine colony-stimulating factors (natural CSF-1, recombinant GM-CSF, and recombinant IL-3) on the in vitro proliferation of purified murine granulocyte-macrophage progenitor cells.
    Williams DE, Straneva JE, Cooper S, Shadduck RK, Waheed A, Gillis S, Urdal D, Broxmeyer HE.
    Exp Hematol; 1987 Nov 01; 15(10):1007-12. PubMed ID: 3311784
    [Abstract] [Full Text] [Related]

  • 14. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G.
    Exp Hematol; 1993 Mar 01; 21(3):432-7. PubMed ID: 8095026
    [Abstract] [Full Text] [Related]

  • 15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 01; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 16. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS, Hughes NK, Tse KF.
    Growth Regul; 1994 Jun 01; 4(2):41-7. PubMed ID: 7950902
    [Abstract] [Full Text] [Related]

  • 17. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.
    Grant S, Pettit GR, Howe C, McCrady C.
    Leukemia; 1991 May 01; 5(5):392-8. PubMed ID: 2033960
    [Abstract] [Full Text] [Related]

  • 18. Effects of recombinant murine granulocyte-macrophage colony-stimulating factor in cyclophosphamide-treated mice.
    Gamba-Vitalo C, DiGiovanna MP, Sartorelli AC.
    Blood Cells; 1991 May 01; 17(1):193-205; discussion 206-8. PubMed ID: 2018856
    [Abstract] [Full Text] [Related]

  • 19. Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells.
    Ottmann OG, Pelus LM.
    J Immunol; 1988 Apr 15; 140(8):2661-5. PubMed ID: 3258618
    [Abstract] [Full Text] [Related]

  • 20. The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors.
    Grillon C, Bonnet D, Mary JY, Lenfant M, Najman A, Guigon M.
    Stem Cells; 1993 Sep 15; 11(5):455-64. PubMed ID: 8241956
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.